These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9754585)

  • 1. Reversible left ventricular dysfunction in the setting of coronary occlusive disease.
    Bache RJ
    J Card Fail; 1998 Sep; 4(3):155-8. PubMed ID: 9754585
    [No Abstract]   [Full Text] [Related]  

  • 2. Revascularization in Patients With Severe Left Ventricular Dysfunction: Is the Assessment of Viability Still Viable?
    Anavekar NS; Chareonthaitawee P; Narula J; Gersh BJ
    J Am Coll Cardiol; 2016 Jun; 67(24):2874-87. PubMed ID: 27311527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The basis of chronic ischemic reversible left ventricular dysfunction (hibernating myocardium)].
    Mates M; Veselka J
    Cesk Fysiol; 1999 Feb; 48(1):4-8. PubMed ID: 10377599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pathophysiology of myocardial ischemia].
    Baumgart D; Heusch G
    Klin Anasthesiol Intensivther; 1995; 47():3-45. PubMed ID: 7715178
    [No Abstract]   [Full Text] [Related]  

  • 5. Prolonged left ventricular dysfunction occurs in patients with coronary artery disease after both dobutamine and exercise induced myocardial ischaemia.
    Barnes E; Baker CS; Dutka DP; Rimoldi O; Rinaldi CA; Nihoyannopoulos P; Camici PG; Hall RJ
    Heart; 2000 Mar; 83(3):283-9. PubMed ID: 10677406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive assessment of myocardial stunning from short-term coronary occlusion using tagged magnetic resonance imaging.
    Kraitchman DL; Hillenbrand HB; Oznur I; Lima JA; McVeigh ER; Zerhouni EA; Bluemke DA
    J Cardiovasc Magn Reson; 2000; 2(2):123-36. PubMed ID: 11545128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial stunning and hibernation.
    Rinaldi CA; Hall RJ
    Indian Heart J; 1996; 48(6):721-5. PubMed ID: 9062030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cardiac decompensation: mechanism of reversibility].
    Melin J; Vanoverschelde JL
    Bull Mem Acad R Med Belg; 1997; 152(1):101-8; discussion 108-11. PubMed ID: 9491624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that stunning can be cumulative in man.
    Rinaldi CA; Hall RJ
    Heart Fail Rev; 2003 Apr; 8(2):161-5. PubMed ID: 12766495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The hibernating myocardium].
    Kirkebøen KA
    Tidsskr Nor Laegeforen; 1995 Jun; 115(16):1934-8. PubMed ID: 7638844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reversible dysfunction of the left ventricle in coronary disease (part two): hibernation and methods for detection of viability].
    Vlahović A; Popović A
    Med Pregl; 2000; 53(3-4):146-53. PubMed ID: 10965679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular dysfunction due to the new ischemic outcomes: stunning and hibernation.
    Ferrari R; Ceconi C; Curello S; Benigno M; La Canna G; Visioli O
    J Cardiovasc Pharmacol; 1996; 28 Suppl 1():S18-26. PubMed ID: 8891867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of functional recovery in patients with chronic coronary artery disease and left ventricular dysfunction combining the evaluation of myocardial perfusion and of contractile reserve using nitrate-enhanced technetium-99m sestamibi gated single-photon emission computed tomography and dobutamine stress.
    Leoncini M; Marcucci G; Sciagrà R; Frascarelli F; Simonetti I; Bini L; Maioli M; Mennuti A; Dabizzi RP
    Am J Cardiol; 2001 Jun; 87(12):1346-50. PubMed ID: 11397351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial stunning in man.
    Barnes E; Khan MA
    Heart Fail Rev; 2003 Apr; 8(2):155-60. PubMed ID: 12766494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial blood flow, glucose uptake, and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction. Implications for the pathophysiology of chronic myocardial hibernation.
    Gerber BL; Vanoverschelde JL; Bol A; Michel C; Labar D; Wijns W; Melin JA
    Circulation; 1996 Aug; 94(4):651-9. PubMed ID: 8772684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial viability: unresolved issues.
    Iskandrian AS
    J Nucl Med; 1996 May; 37(5):794-7. PubMed ID: 8965147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Echocardiographic diagnosis of segmental wall motion abnormalities.
    Siostrzonek P; Mundigler G; Hassan A; Zehetgruber M
    Acta Anaesthesiol Scand Suppl; 1997; 111():271-4. PubMed ID: 9421042
    [No Abstract]   [Full Text] [Related]  

  • 18. Myocardial viability.
    Birnbaum Y; Kloner RA
    West J Med; 1996 Dec; 165(6):364-71. PubMed ID: 9000857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood flow in myocardial hibernation.
    Camici PG; Rimoldi O
    Curr Opin Cardiol; 1998 Nov; 13(6):409-14. PubMed ID: 9822873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial hibernation and stunning: from physiological principles to clinical practice.
    Redwood SR; Ferrari R; Marber MS
    Heart; 1998 Sep; 80(3):218-22. PubMed ID: 9875076
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.